Michael Juchum

477 total citations
10 papers, 376 citations indexed

About

Michael Juchum is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Juchum has authored 10 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Juchum's work include Lung Cancer Treatments and Mutations (5 papers), Cancer therapeutics and mechanisms (4 papers) and Melanoma and MAPK Pathways (4 papers). Michael Juchum is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Cancer therapeutics and mechanisms (4 papers) and Melanoma and MAPK Pathways (4 papers). Michael Juchum collaborates with scholars based in Germany, Finland and New Zealand. Michael Juchum's co-authors include Stefan Laufer, Marcel Günther, Eva Döring, Heiner Fiebig, Gerhard Kelter, Adrian Sievers‐Engler, Michael Lämmerhofer, Julian Engel, Jonas Lategahn and Hannah L. Tumbrink and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Michael Juchum

10 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Juchum Germany 7 262 187 150 146 30 10 376
Marina Keul Germany 9 211 0.8× 123 0.7× 144 1.0× 110 0.8× 21 0.7× 16 307
Julian Engel Germany 11 290 1.1× 142 0.8× 187 1.2× 154 1.1× 29 1.0× 14 452
Xiao-E Yan China 9 173 0.7× 158 0.8× 117 0.8× 139 1.0× 14 0.5× 10 321
Stefanie Heynck Germany 6 228 0.9× 285 1.5× 95 0.6× 249 1.7× 25 0.8× 6 418
Camille Prével France 6 204 0.8× 100 0.5× 72 0.5× 168 1.2× 46 1.5× 8 371
Jacob I. Contreras United States 10 344 1.3× 85 0.5× 124 0.8× 195 1.3× 33 1.1× 12 536
Bo Hee Shin United States 7 344 1.3× 265 1.4× 95 0.6× 259 1.8× 25 0.8× 7 505
Rich Woessner United States 9 161 0.6× 96 0.5× 86 0.6× 131 0.9× 30 1.0× 17 326
Mierzhati Mushajiang United States 6 384 1.5× 329 1.8× 102 0.7× 295 2.0× 34 1.1× 6 547
Tyler S. Beyett United States 11 237 0.9× 96 0.5× 82 0.5× 108 0.7× 25 0.8× 25 369

Countries citing papers authored by Michael Juchum

Since Specialization
Citations

This map shows the geographic impact of Michael Juchum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Juchum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Juchum more than expected).

Fields of papers citing papers by Michael Juchum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Juchum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Juchum. The network helps show where Michael Juchum may publish in the future.

Co-authorship network of co-authors of Michael Juchum

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Juchum. A scholar is included among the top collaborators of Michael Juchum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Juchum. Michael Juchum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Juchum, Michael, et al.. (2022). Scaffold modified Vemurafenib analogues as highly selective mitogen activated protein kinase kinase 4 (MKK4) inhibitors. European Journal of Medicinal Chemistry. 240. 114584–114584. 6 indexed citations
2.
Juchum, Michael, et al.. (2021). Design and synthesis of 1H-pyrazolo[3,4-b]pyridines targeting mitogen-activated protein kinase kinase 4 (MKK4) - A promising target for liver regeneration. European Journal of Medicinal Chemistry. 218. 113371–113371. 15 indexed citations
3.
Juchum, Michael, et al.. (2020). From off-to on-target: New BRAF-inhibitor-template-derived compounds selectively targeting mitogen activated protein kinase kinase 4 (MKK4). European Journal of Medicinal Chemistry. 210. 112963–112963. 13 indexed citations
4.
Pantsar, Tatu, et al.. (2020). Design and synthesis of novel fluorescently labeled analogs of vemurafenib targeting MKK4. European Journal of Medicinal Chemistry. 209. 112901–112901. 6 indexed citations
5.
Günther, Marcel, Jonas Lategahn, Michael Juchum, et al.. (2017). Trisubstituted Pyridinylimidazoles as Potent Inhibitors of the Clinically Resistant L858R/T790M/C797S EGFR Mutant: Targeting of Both Hydrophobic Regions and the Phosphate Binding Site. Journal of Medicinal Chemistry. 60(13). 5613–5637. 81 indexed citations
6.
Juchum, Michael, Marcel Günther, Eva Döring, et al.. (2017). Trisubstituted Imidazoles with a Rigidized Hinge Binding Motif Act As Single Digit nM Inhibitors of Clinically Relevant EGFR L858R/T790M and L858R/T790M/C797S Mutants: An Example of Target Hopping. Journal of Medicinal Chemistry. 60(11). 4636–4656. 61 indexed citations
7.
Günther, Marcel, Michael Juchum, Gerhard Kelter, Heiner Fiebig, & Stefan Laufer. (2016). Lung Cancer: EGFR Inhibitors with Low Nanomolar Activity against a Therapy‐Resistant L858R/T790M/C797S Mutant. Angewandte Chemie International Edition. 55(36). 10890–10894. 79 indexed citations
8.
Günther, Marcel, Michael Juchum, Gerhard Kelter, Heiner Fiebig, & Stefan Laufer. (2016). Lungenkrebs: EGFR‐Inhibitoren mit hoher Wirksamkeit gegen die therapieresistente L858R/T790M/C797S‐Mutante.. Angewandte Chemie. 128(36). 11050–11054. 6 indexed citations
9.
Janzen, Daron E., Michael Juchum, Tanya K. Ronson, et al.. (2016). Trigonal (-3) symmetry octahedral lanthanide(III) complexes of zwitterionic tripodal ligands: luminescence and magnetism. Supramolecular chemistry. 28(1-2). 125–140. 2 indexed citations
10.
Juchum, Michael, Marcel Günther, & Stefan Laufer. (2015). Fighting cancer drug resistance: Opportunities and challenges for mutation-specific EGFR inhibitors. Drug Resistance Updates. 20. 12–28. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marina Keul Breakdown of academic impact, for papers by Julian Engel Breakdown of academic impact, for papers by Xiao-E Yan Breakdown of academic impact, for papers by Stefanie Heynck Breakdown of academic impact, for papers by Camille Prével Breakdown of academic impact, for papers by Jacob I. Contreras Breakdown of academic impact, for papers by Bo Hee Shin Breakdown of academic impact, for papers by Rich Woessner Breakdown of academic impact, for papers by Mierzhati Mushajiang Breakdown of academic impact, for papers by Tyler S. Beyett
Rankless by CCL
2026